Drug and medical device companies paid $6.49 billion to physicians and teaching hospitals in 2014, according to the second round of data published through the CMS' Open Payments website.
Provider-focused approaches to scheduling and failure to appropriately use nurse practitioners and physician assistants are among the reasons timely access to care remains a problem in the U.S., according to an Institute of Medicine report.
The U.S. Supreme Court's decision last week to legalize same-sex marriage across the country will have mixed effects for same-sex couples when it comes to Medicaid. Experts say the ruling will affect coverage rules for both Medicaid medical and long-term-care benefits.
Matthew Trunnell has been appointed VP and CIO at Fred Hutchinson Cancer Research Center, a Seattle-based independent not-for-profit research institute.
High deductibles have already been linked to an increase in bad debt at some health systems, but now they may be responsible for holding down volume as well.
In an industry that's been rapidly consolidating, Catholic Health Initiatives has had a particularly rapid growth trajectory. The Englewood, Colo.-based system has struggled to contain costs associated with acquiring new hospitals. But CHI is improving in its core business, which could bode well...
The home-care sector is keeping an eye out for an expected move by the White House to make up to 5 million more people eligible for overtime pay. Some say it could benefit fee-based employees while others believe it could cause employers to scale back on hiring specialized workers.
The U.S. Supreme Court will hear a case asking it to limit the power of public unions to collect fees from nonmembers. The case could threaten the finances and membership efforts of unions that represent healthcare workers at publicly owned providers.
Ascension intends to sell two Pacific Northwest hospitals to for-profit Capella Healthcare for undisclosed terms.
Leading biotech firm Celgene Corp. will pay $1 billion to enter into a 10-year collaboration with Juno Therapeutics. The move broadens the company's cancer drug portfolio by gaining access to Juno's budding pipeline of oncology immunotherapies.
Federal prosecutors have reached a $20.3 million civil settlement with Community Health Network to resolve allegations of overbilling for surgeries.
A report from the Institute of Medicine suggests revamping the national strategy for cardiac arrest to standardize surveillance, coordination, data collection, public education and the sharing of best practices pertaining to the condition.